newsfilter
← Latest News
Business Wire·

Positive Results from Pivotal Trial of Better Therapeutics' Investigational BT-001 Prescription Digital Therapy for Type 2 Diabetes Published in Diabetes Care

ADA-published, peer-reviewed journal article highlights positive primary endpoint data from trial evaluating digitally delivered approach to diabetes management Better Therapeutics, Inc. (NASDAQ:BTTX), a prescription digital therapeutics (PDT) compan